Establishment in December 2013 of the Company spin-off Biosfer Teslab. The entrepreneurial team is formed Roger Mallol, Nuria Amigo Xavier Correig and Lluís Masana. The first three are members of the Metabolomics Platform group. They have developed a product consisting of a computer-based tool capable of measuring the particle number and size of different lipoprotein subclasses from proton nuclear magnetic resonance spectra of serum/plasma.